Risks, prognostic factors, and clinicopathologic features of methotrexate-induced epidermal necrosis in patients with rheumatic diseases
博士 === 國立陽明大學 === 藥理學研究所 === 105 === Background: Methotrexate is widely used in treating many diseases; however, it can cause a rare but life-threatening cutaneous adverse reaction, namely, methotrexate-induced epidermal necrosis (MEN), mimicking Stevens-Johnson syndrome (SJS)/toxic epidermal necrol...
Main Authors: | Ting-Jui Chen, 陳亭睿 |
---|---|
Other Authors: | Shuen-Iu Hung |
Format: | Others |
Language: | en_US |
Published: |
2017
|
Online Access: | http://ndltd.ncl.edu.tw/handle/5k36w7 |
Similar Items
-
Methotrexate in the treatment of rheumatic disease
by: Marina Zinovyevna Kanevskaya, et al.
Published: (2013-12-01) -
Use of coffee for alleviating methotrexate intolerance in rheumatic diseases
by: Anand Narayan Malaviya, et al.
Published: (2019-01-01) -
Methotrexate-induced toxic epidermal necrolysis in a child
by: Ajay Gogia, et al.
Published: (2013-01-01) -
Portuguese recommendations for the use of methotrexate in rheumatic diseases - 2016 update
by: Ana Catarina Duarte, et al.
Published: (2017-04-01) -
Erratum: Use of coffee for alleviating methotrexate intolerance in rheumatic diseases
Published: (2019-01-01)